Tremelimumab, CAS 745013-59-6

Product Description: Tremelimumab (Ticilimumab) is a fully human monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Comin-Anduix B, et al. Tremelimumab: research and clinical development. Onco Targets Ther. 2016 Mar 23;9:1767-76.

CAS Number: 745013-59-6

Molecular Weight: N/A

Compound Purity: 99.50

Research Area: Cancer; Inflammation/Immunology

Solubility: H2O

Target: CTLA-4

• SKU: MEXHY-P9918-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P9918-1
• Green Labware: No
• Package Unit: 1 mg
• Quantity Unit: STK